Summary The National Cancer Institute's Clinical Proteomic Tumor Analysis Consortium
(CPTAC) investigates tumors from a proteogenomic perspective, creating rich multi-omics …

Rheumatoid arthritis (RA) is an incurable systemic autoimmune disease. Disease
progression leads to joint deformity and associated loss of function, which significantly …

MicroRNAs (miRNAs) are non-coding RNAs which are essential post-transcriptional gene
regulators in various neuronal degenerative diseases and playact a key role in these …

Background miRNAs regulate the expression of several genes with one miRNA able to
target multiple genes and with one gene able to be simultaneously targeted by more than …

The minimally—or non-invasive detection of circulating tumor-derived components in
biofluids, such as blood, liquid biopsy is a revolutionary approach with significant potential …

The evidence suggests that diet can modulate endogenous microRNA (miRNA) expression.
Changes in miRNA expression may affect metabolic processes and consequently be …

In the past decade, there has been a shift in research, clinical development, and commercial
activity to exploit the many physiological roles of RNA for use in medicine. With the rapid …

Gastric cancer (GC) is a heterogeneous disease, threatening millions of lives worldwide, yet
the functional roles of long non-coding RNAs (lncRNAs) in different GC subtypes remain …

Inferring small molecule-miRNA associations (MMAs) is crucial for revealing the intricacies
of biological processes and disease mechanisms. Deep learning, renowned for its …

Discovered in 1993, micoRNAs (miRNAs) are now recognized as one of the major
regulatory gene families in eukaryotes. To date, 24521 microRNAs have been discovered …